2024-09-16 - Analysis Report
## CVS Stock Analysis Report

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and health services.

**1. Performance vs. S&P 500 (VOO):**

CVS has underperformed significantly compared to the S&P 500. The cumulative return of CVS is -20.34%, while the S&P 500 has returned 88.73%. This represents a significant difference of -109.07%. The relative divergence of -109.07% means that CVS has been performing much worse than the S&P 500 in recent times.

**2. Recent Price Movement:**

* **Closing Price:** $57.98
* **5-day Moving Average:** $57.01
* **20-day Moving Average:** $57.8
* **60-day Moving Average:** $58.47

The stock price is currently trading slightly above the 5-day moving average and 20-day moving average, suggesting some recent buying interest. However, it remains below the 60-day moving average, indicating a possible short-term downtrend.

**3. Technical Indicators Analysis:**

* **RSI:** 46.19 - This suggests the stock is neither overbought nor oversold, with potential for further price movement in both directions.
* **PPO:** 0.03 - A positive PPO value indicates a bullish momentum, suggesting a potential upward price movement.
* **Delta_Previous_Relative_Divergence:** -1.64 - This indicates a short-term downward trend.
* **Expected_Return:** 12.44% - This represents the potential 5-year maximum return on investment, a positive indicator for long-term investors.

**4. Recent Earnings Performance:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report for the quarter ending August 2024 showed an EPS of $1.83, exceeding the expected EPS of $1.73. This indicates strong earnings performance, which could be positive for the stock price in the future.

**5. Overall Analysis:**

CVS has significantly underperformed compared to the S&P 500 in recent times. However, the stock price is currently trading slightly above its 5-day and 20-day moving averages, showing some recent buying interest. Additionally, the company's most recent earnings report indicates strong performance. While technical indicators suggest a possible short-term downtrend, the positive expected return and recent earnings performance make CVS a potential investment opportunity for long-term investors.

**6. Conclusion:**

CVS Health Corporation is a company with a strong presence in the healthcare industry. Despite its recent underperformance compared to the S&P 500, the company's positive earnings report and potential long-term return make it a viable investment option for investors seeking long-term growth. However, it is essential to monitor the stock's price movement and technical indicators closely to assess short-term trends.